| Management number | 238806550 | Release Date | 2026/07/11 | List Price | $29.14 | Model Number | 238806550 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
CaniBendan is indicated for the management of signs of mild, moderate, or severe congestive heart failure in dogs, due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). CaniBendan can be used in concurrent CHF therapy (e.g., furosemide) as appropriate on a case-by-case basis
| Brand | PHARMACY |
|---|---|
| Animal type | Dog |
| Animal health concern | Heart Care |
| Animal lifestage | All Lifestages |
| Medicine form | Oral |
| Enteral medication form | Tablets |
| Pieces | 50 |
| Product net content parent | 50 Each |
| Product net content uom | Each |
| Label image | No Label |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form